Memantine 5mg Tablets

Memantine 5mg is an NMDA receptor antagonist used for moderate to severe Alzheimer's disease dementia for memantine treatment. It does not cure Alzheimer's disease, restore lost memory completely, or stop disease progression permanently, but it may help some patients with cognition, behavior, daily function, or caregiver burden for a period. Memantine modulates glutamate activity at NMDA receptors, which may reduce excessive excitatory signaling involved in dementia symptoms. Caregivers should monitor falls, agitation, worsening confusion, sleep changes, constipation, urination problems, and whether daily function is improving, stable, or worsening.
Take Memantine 5mg exactly as prescribed, at the same time each day if possible. Dose may be titrated gradually. Caregivers should track function, behavior, falls, and tolerability.
Memantine blocks NMDA receptor activity in a regulated way, helping modulate excess glutamate signaling associated with Alzheimer's disease symptoms.
Possible effects include dizziness, headache, constipation, sleepiness, confusion, hallucinations, high blood pressure, and tiredness. Serious concerns include seizures, severe allergic reaction, severe agitation, or marked worsening confusion.
Review kidney disease, seizure history, urinary problems, liver disease, pregnancy, breastfeeding, alkaline urine conditions, sodium bicarbonate use, acetazolamide, carbonic anhydrase inhibitors, amantadine, ketamine, and dextromethorphan.
Moderate to severe Alzheimer's disease dementia when memantine therapy is prescribed.
May help cognition, behavior, or daily function for some patients, with caregiver-observed response guiding continuation.
Memantine 5mg is used for moderate to severe Alzheimer's disease dementia when prescribed.
No. It may help symptoms in some people but does not cure or permanently stop progression.
Gradual titration can reduce dizziness, confusion, and other side effects.
Memantine is affected by kidney clearance, and significant impairment may require dose adjustment.
Daily function, behavior, falls, constipation, hallucinations, sleepiness, and sudden changes should be tracked.
Memantine hydrochloride, Alzheimer's dementia medicine, NMDA receptor antagonist, Caregiver monitoring, Kidney dose adjustment, Confusion dizziness, AR: Memantine Hydrochloride أقراص, FR: Memantine Hydrochloride comprimé, PT: Memantine Hydrochloride comprimido, ES: Memantine Hydrochloride tableta, RU: Memantine Hydrochloride таблетки, ID: Memantine Hydrochloride, VI: Memantine Hydrochloride viên nén, MS: Memantine Hydrochloride, TL: Memantine Hydrochloride tableta, ZH-SG: Memantine Hydrochloride 片剂
International B2B Enquiry
Send a structured B2B enquiry for Memantine 5mg Tablets under Neuro Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Memantine 5mg Tablets